Thrivent Financial for Lutherans’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.96M | Buy |
91,067
+626
| +0.7% | +$13.5K | ﹤0.01% | 1371 |
|
|
2025
Q1 | $1.5M | Buy |
+90,441
| New | +$1.5M | ﹤0.01% | 1447 |
|
|
2024
Q3 | – | Sell |
-78,292
| Closed | -$1.27M | – | 2507 |
|
|
2024
Q2 | $1.27M | Sell |
78,292
-3,343
| -4% | -$54.3K | ﹤0.01% | 1705 |
|
|
2024
Q1 | $1.51M | Buy |
81,635
+23,790
| +41% | +$440K | ﹤0.01% | 1622 |
|
|
2023
Q4 | $1.81M | Buy |
57,845
+46,918
| +429% | +$1.47M | ﹤0.01% | 1445 |
|
|
2023
Q3 | $228K | Sell |
10,927
-195,729
| -95% | -$4.08M | ﹤0.01% | 2366 |
|
|
2023
Q2 | $4.95M | Sell |
206,656
-59,988
| -22% | -$1.44M | 0.01% | 857 |
|
|
2023
Q1 | $5.02M | Buy |
266,644
+184,505
| +225% | +$3.47M | 0.01% | 809 |
|
|
2022
Q4 | $1.31M | Sell |
82,139
-87,367
| -52% | -$1.39M | ﹤0.01% | 1558 |
|
|
2022
Q3 | $2.77M | Buy |
+169,506
| New | +$2.77M | 0.01% | 1032 |
|
|
2022
Q1 | – | Sell |
-348,107
| Closed | -$8.13M | – | 2494 |
|
|
2021
Q4 | $8.13M | Sell |
348,107
-363,060
| -51% | -$8.47M | 0.02% | 742 |
|
|
2021
Q3 | $11.8M | Sell |
711,167
-10,379
| -1% | -$172K | 0.02% | 618 |
|
|
2021
Q2 | $17.6M | Sell |
721,546
-165,367
| -19% | -$4.03M | 0.04% | 498 |
|
|
2021
Q1 | $22.9M | Buy |
886,913
+96,836
| +12% | +$2.5M | 0.05% | 407 |
|
|
2020
Q4 | $42.2M | Buy |
790,077
+14,925
| +2% | +$798K | 0.1% | 269 |
|
|
2020
Q3 | $32M | Buy |
+775,152
| New | +$32M | 0.09% | 281 |
|